glp 1 agonist fda approved for weight loss approves Lilly's Foundayo (orforglipron) GLP-1 pill Market Overview: GLP-1 Agonists and

Next up: glucagon-like peptide 1 receptor agonists, known colloquially (and identified here) as GLPs

Preclinical and initial human studies suggest that glucagon-like peptide-1 receptor agonists may be promising treatments for alcohol use disorder, but existing approved treatments should be used until safety and efficacy is demonstrated in clinical trials.

Shocking Truth: Compounded GLP-1s on Groupon pose serious health risks

Pills that work in a similar way could be a cheaper, simpler solution.

Primary outcomes included serious adverse events and retained gastric products based on patient records, procedure reports, and procedural videos